REST Restore Medical (MM)

Restore Medical, Inc. (Nasdaq:REST) today announced that the company will release 2007 second quarter results on Thursday, August 2, 2007. Bob Paulson, president and chief executive officer, and Chris Geyen, chief financial officer, will host an investment community conference call beginning at 5:00 p.m. Eastern Time on August 2, 2007 to discuss these results and to answer questions. To participate in the live call by telephone, please dial (800) 642-1381 from the U.S., or for international callers, please dial (706) 634-7417. The conference ID # is: 11192565. Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of Restore Medical�s web site at http://restoremedical.com. To listen to the live call, please go to the web site 15 minutes prior to its start to register, download, and install the necessary audio software. A replay will be available on the web site. A telephone replay will be available from 7:00 p.m. Eastern Time on August, 2, 2007 through 11:59 p.m. Eastern Time on August 4, 2007 by dialing (800) 642-1687 (domestic) or (706) 645-9291 (international) and entering conference ID number 11192565. About Restore Medical and the Pillar Procedure Restore Medical develops, manufactures and markets innovative medical devices to treat sleep-disordered breathing. The Company's proprietary Pillar� Palatal Implant System is the only implantable palatal device to treat snoring and mild to moderate obstructive sleep apnea to be approved by the U.S. Food and Drug Administration and by Health Canada, and to have received the CE Mark for sale in the European Union. The Pillar Palatal Implant System is sold throughout the U.S. and Canada, and in various countries in Asia Pacific, Europe, South America and the Middle East. For more information about Restore Medical, the Pillar Procedure and physicians who offer the Pillar Procedure in the U.S., visit the company�s website at www.restoremedical.com or www.pillarprocedure.com.